We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
iShares Russell 2000 Growth ETF
IWO
$14.5B
| $3.36M | 0.02% |
20,777
-22
| -0.1% | -$3.49K |
|
477
Charles River Laboratories
CRL
$10.9B
| $3.36M | 0.02% |
37,326
-6,779
| -15% | -$576K |
|
478
Alibaba
BABA
$269B
| $3.34M | 0.02% |
31,004
+11,629
| +60% | +$1.18M |
|
479
Costco
COST
$415B
| $3.34M | 0.02% |
19,921
-1,659
| -8% | -$278K |
|
480
Rockwell Automation
ROK
$51.4B
| $3.32M | 0.02% |
21,304
+8,368
| +65% | +$1.25M |
|
481
Cedar Fair
FUN
$1.78B
| $3.3M | 0.02% |
48,682
-701
| -1% | -$46K |
|
482
Teradata
TDC
$2.68B
| $3.3M | 0.02% |
106,114
-357,859
| -77% | -$10.8M |
|
|
PBCT
483
DELISTED
People's United Financial Inc
PBCT
| $3.28M | 0.02% |
180,268
+7,999
| +5% | +$151K |
|
484
State Street Utilities Select Sector SPDR ETF
XLU
$24.1B
| $3.27M | 0.02% |
127,662
-4,216
| -3% | -$105K |
|
485
Aflac
AFL
$63.9B
| $3.27M | 0.02% |
90,434
-74,832
| -45% | -$2.65M |
|
486
iShares MSCI EAFE Value ETF
EFV
$27.6B
| $3.26M | 0.02% |
64,858
+5,320
| +9% | +$261K |
|
487
Cadence Design Systems
CDNS
$90B
| $3.26M | 0.02% |
103,721
-1,278,575
| -92% | -$37.3M |
|
|
HDV
488
iShares Core High Dividend ETF
HDV
$14.4B
| $3.25M | 0.02% |
194,095
-5,500
| -3% | -$91.7K |
|
489
Alliant Energy
LNT
$19.4B
| $3.19M | 0.02% |
80,443
-17,751
| -18% | -$681K |
|
490
M&T Bank
MTB
$36.2B
| $3.18M | 0.02% |
20,549
+1,989
| +11% | +$322K |
|
|
TEP
491
DELISTED
Tallgrass Energy Partners, LP
TEP
| $3.17M | 0.02% |
59,537
-7,228
| -11% | -$370K |
|
492
Lincoln National
LNC
$7.91B
| $3.16M | 0.02% |
48,352
-12,300
| -20% | -$841K |
|
493
Regeneron Pharmaceuticals
REGN
$68.8B
| $3.16M | 0.02% |
8,155
-587
| -7% | -$218K |
|
|
CDK
494
DELISTED
CDK Global, Inc.
CDK
| $3.13M | 0.02% |
48,229
-2,935
| -6% | -$188K |
|
495
Huntington Bancshares
HBAN
$35.1B
| $3.12M | 0.01% |
233,373
-20,048
| -8% | -$274K |
|
496
Enbridge
ENB
$124B
| $3.1M | 0.01% |
74,138
+67,067
| +948% | +$2.83M |
|
497
iShares Russell 2000 Value ETF
IWN
$14.4B
| $3.1M | 0.01% |
26,235
+23
| +0.1% | +$2.73K |
|
498
Vanguard Information Technology ETF
VGT
$139B
| $3.08M | 0.01% |
181,736
-13,120
| -7% | -$214K |
|
499
Arrow Electronics
ARW
$10.9B
| $3.06M | 0.01% |
41,668
+1,517
| +4% | +$111K |
|
500
Newmont
NEM
$98.2B
| $3.03M | 0.01% |
91,854
+1,117
| +1% | +$39K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.